Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug metabolism enzyme activity and pharmacokinetics in obese men
ChiCTR2200057996Phase 4Not yet recruiting
- Sponsor
- Beijing Friendship Hospital
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of midazolam and febuxostat in obesity (3 arms), sponsored by Beijing Friendship Hospital. Primary endpoints: Pharmacokinetics, Drug metabolism enzyme activity and 2 more. Planned start Mar 2022; status: not yet recruiting.
02
Drugs
midazolamfebuxostat
03
Conditions
obesity
Beyond the preview
Go deeper on ChiCTR2200057996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057996.